- Round ID
- FR-00288
- Stage
- Series B
- Round name
- Series B
- Amount
- £39.5M
Dated funding evidence
Grey Wolf Therapeutics
Series B · £39.5M · 2023-01-01
Reported round£39.5MSeries B
- Disclosure date
- 2023-01-01
- Reported currency
- GBP
- Companies House
- 10989365
- Evidence sources
- 2
2023-01-01Series B£39.5M
Resolved investor records
No named investor resolved to an exact canonical investor record.
2 additional source-listed names are retained in the record fields below but not linked without an exact canonical match.
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- not specified in source
- Other investors
- British Patient Capital (per BPC 2023 direct-investment list)
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.